🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

135,26 USD

Máx. histórico

158,62

80 días

Caída desde máximo

-14,73%

Rango 52 semanas

76,70 – 160,81

Variación hoy

-5,66%

Cierre anterior

143,37

Rango de hoy

134,39 – 143,30

Volumen hoy

582.605

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,33%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
131,32 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 5 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/02/2021 24,84 25,34 24,36 25,09 +2,03% 3,95% 306.500
10/02/2021 25,78 26,16 24,11 24,59 -3,79% 7,95% 278.300
09/02/2021 24,72 26,37 24,18 25,56 +3,73% 8,86% 466.600
08/02/2021 22,76 24,66 22,55 24,64 +10,10% 9,27% 261.200
05/02/2021 21,79 23,06 21,64 22,38 +4,38% 6,52% 362.300
04/02/2021 21,47 21,86 21,08 21,44 -0,65% 3,63% 169.900
03/02/2021 22,23 22,41 21,39 21,58 -1,69% 4,59% 208.500
02/02/2021 21,09 22,05 20,60 21,95 +5,89% 6,88% 411.100
01/02/2021 21,06 21,40 20,11 20,73 +0,10% 6,13% 364.200
29/01/2021 21,51 22,11 20,13 20,71 -2,59% 9,21% 306.300
28/01/2021 21,03 21,97 20,89 21,26 +2,90% 5,14% 198.300
27/01/2021 22,40 22,70 20,53 20,66 -10,52% 9,69% 405.600
26/01/2021 23,91 24,41 22,95 23,09 -2,29% 6,11% 272.700
25/01/2021 22,34 23,72 22,11 23,63 +5,68% 7,21% 197.800
22/01/2021 23,27 23,69 22,16 22,36 -5,01% 6,57% 317.800
21/01/2021 24,50 24,56 22,94 23,54 -4,15% 6,61% 357.000
20/01/2021 24,94 25,50 24,00 24,56 -1,05% 6,01% 429.400
19/01/2021 24,93 24,97 23,94 24,82 +1,85% 4,13% 559.900
15/01/2021 23,27 24,62 23,13 24,37 +6,65% 6,40% 758.600
14/01/2021 21,58 23,25 21,51 22,85 +7,13% 8,06% 365.200
13/01/2021 21,31 22,14 20,94 21,33 +0,57% 5,63% 343.300
12/01/2021 20,53 21,64 20,53 21,21 +2,86% 5,41% 416.400
11/01/2021 20,39 21,18 20,12 20,62 -0,15% 5,20% 250.300
08/01/2021 20,99 21,47 20,20 20,65 -2,41% 6,05% 413.500
07/01/2021 19,69 21,45 19,69 21,16 +7,47% 8,94% 417.600
06/01/2021 19,85 20,27 18,82 19,69 +3,52% 7,30% 840.200
05/01/2021 19,55 20,12 18,88 19,02 -2,96% 6,34% 744.700
04/01/2021 20,31 20,50 19,36 19,60 -2,78% 5,61% 462.800
31/12/2020 20,05 20,37 19,25 20,16 +0,85% 5,59% 922.500
30/12/2020 21,34 21,34 19,21 19,99 -6,46% 9,98% 1.621.400